Albert Cha
Insider Reports History
- Location
- Palo Alto, CA
- Signature
- /s/ Michael Wolff Jensen as attorney-in-fact for Albert Cha
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Albert Cha:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ascendis Pharma A/S | Director | Ordinary Shares | 3,730 | $876,512 | $234.99 | 18 Mar 2026 | Direct |
| KalVista Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 10,000 | 26 Sep 2023 | Direct |
Insider Reports Filed by Albert Cha
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | 18 Mar 2026 | 0 | $0 | 3 | Director | 18 Mar 2026, 18:02 |
| KALV | KalVista Pharmaceuticals, Inc. | 26 Sep 2023 | 1 | $0 | 4 | Director | 28 Sep 2023, 16:52 |
| KALV | KalVista Pharmaceuticals, Inc. | 11 Sep 2023 | 5 | -$54,230 | 4 | Director | 13 Sep 2023, 16:29 |
| KALV | KalVista Pharmaceuticals, Inc. | 13 Oct 2022 | 1 | $0 | 4 | Director | 17 Oct 2022, 18:34 |
| KALV | KalVista Pharmaceuticals, Inc. | 30 Sep 2021 | 1 | $0 | 4 | Director | 01 Oct 2021, 16:53 |